Search results

The BRIGHT Project will expand the beamline infrastructure of the Australian Synchrotron to increase both its capacity and capabilities.

ANSTO’s Australian Synchrotron has been working on an initiative that could substantially improve radiotherapy treatment for cancer patients. 

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

Meeting of minds about potential next-generation cancer treatment for Australians

The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.

Award recipients Dr Richard Garrett and Dr Nigel Lengkeek with Dr Tien Pham will deliver a Distinguished Lecture on 15 November at ANSTO.

Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.

Come and discover the world of science at the Australian Synchrotron - book a school tour today.

$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.

Terahertz/Far Infrared beamlines assisted investigation into possible composition of lower atmosphere of Saturn's moon Titan.

Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,

Combined users meeting highlights how ANSTO expertise and infrastructure can assist research community.

Publications and resources from the Powder Diffraction beamline.